Vision & Mission

Hera-MI focuses its research on artificial intelligence applied to medical imaging, with a particular emphasis on cancer diagnosis.

The company’s objective is to address the future healthcare challenges by enhancing the healthcare system experience through AI.

In this context, Hera-MI is developing software solutions to support medical decision-making, benefiting radiologists, breast specialists, and patients.

In this regard, Hera-MI has introduced a pioneering medical device, Breast-SlimView®. This is a patented decision support software dedicated to 2D and 3D mammography (tomosynthesis), specifically designed for breast cancer diagnostic.

Breast Cancer

Artificial Intelligence


Dedicated to radiologists and patients

Transform your diagnostic approach with our AI solution, providing enhanced security and unparalleled ease of use.

Free yourselves from irrelevant information
and detect suspicious areas at a glance

Request a demo

Breast-SlimView® offers an innovative reading support that stands out by presenting only relevant information.


Exclusive Interview with a Radiologist

View more

DeepLearn2023 – Detection of Breast Microcalcifications

View more

Our first installation in Bulgaria

View more

A patented clinical decision solution
for 2D and 3D mammography


Meet us at tradeshows, conferences, and events.


Find more


Find scientific articles on Artificial Intelligence

in radiology and breast cancer

Find more

A faster and improved breast cancer diagnosis

Subscribe to our newsletter

You wish to stay up to date on Hera-MI & BSV? Don’t miss our latest news & subscribe to our newsletter!

Follow us